PATENT CLAIM ANALYSIS

Application Number: 15772859
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["546", "193000"]

Abstract:
The present invention relates to a novel [1,2,4]triazolo[1,5-a]pyrimidin-yl derivative as inhibitor of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compound, to processes for preparing such compound and compositions, and to the use of such compound and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorder.

Claim (Index 1):
A compound having the formula (1) or a pharmaceutically acceptable salt or a solvate thereof.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 93.0
- Lexical Diversity: 1.59574
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14410497', '15291948', '14413775', '14128835', '15533527']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7743785909830295
- 35 USC 102 Novelty (BERT): 0.5171151247331833
- Combined Prediction Score: 0.7486522443580449
- Mean Citation Score: 287.8944
- Max Citation Score: 302.3540000000001
- Similarity Product: 231.4771300146581

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test